Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.
Ozsahin M, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Dinçbas FO, Landmann C, Castelain B, Buijsen J, Curschmann J, Kadish SP, Kowalczyk A, Anacak Y, Hammer J, Nguyen TD, Studer G, Cooper R, Sengöz M, Scandolaro L, Zouhair A. Ozsahin M, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):210-7. doi: 10.1016/j.ijrobp.2005.06.039. Epub 2005 Oct 17. Int J Radiat Oncol Biol Phys. 2006. PMID: 16229966
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C, Collette L, Bartelink E, Borger JH, Brenninkmeyer SJ, Horiot JC, Pierart M, Poortmans PM, Struikmans H, Van der Schueren E, Van Dongen JA, Van Limbergen E, Bartelink H. Vrieling C, et al. Among authors: poortmans pm. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):667-76. doi: 10.1016/s0360-3016(99)00215-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 10524421 Clinical Trial.
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Van der Hulst M, Van der Schueren E, Bartelink H. Vrieling C, et al. Among authors: poortmans pm. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):677-85. doi: 10.1016/s0360-3016(99)00211-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10524422 Clinical Trial.
Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.
Martinet S, Ozsahin M, Belkacémi Y, Landmann C, Poortmans P, Oehlere C, Scandolaro L, Krengli M, Maingon P, Miralbell R, Studer G, Chauvet B, Marnitz S, Zouhair A, Mirimanoff RO. Martinet S, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):892-8. doi: 10.1016/s0360-3016(02)04159-7. Int J Radiat Oncol Biol Phys. 2003. PMID: 12605966
Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network.
Belkacémi Y, Berger C, Poortmans P, Piel G, Zouhair A, Méric JB, Nguyen TD, Krengli M, Behrensmeier F, Allal A, De Looze D, Bernier J, Scandolaro L, Mirimanoff RO; Rare Cancer Network. Belkacémi Y, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1274-83. doi: 10.1016/s0360-3016(03)00277-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12873671
[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network].
Nguyen TD, Poortmans PM, van der Hulst M, Studer G, Pigois E, Collen TD, Belkacemi Y, Beckendorf V, Miralbell R, Scandolaro L, Soete G, Villa S, Gez E, Thomas O, Krengli M, Saliou M; Rare Cancer Network. Nguyen TD, et al. Among authors: poortmans pm. Bull Cancer. 2004 Dec;91(12):959-64. Bull Cancer. 2004. PMID: 15634636 Free article. French.
Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
Rades D, Veninga T, Stalpers LJ, Schulte R, Hoskin PJ, Poortmans P, Schild SE, Rudat V. Rades D, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):182-8. doi: 10.1016/j.ijrobp.2005.06.036. Epub 2005 Sep 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16198069
The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study.
Nguyen TD, Poortmans PM, van der Hulst M, Studer G, Pigois E, Collen TD, Belkacemi Y, Beckendorf V, Miralbell R, Scandolaro L, Soete G, Villa S, Gez E, Thomas O, Krengli M, Jovenin N. Nguyen TD, et al. Among authors: poortmans pm. Radiother Oncol. 2005 Dec;77(3):286-9. doi: 10.1016/j.radonc.2005.10.015. Epub 2005 Nov 22. Radiother Oncol. 2005. PMID: 16307812
Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
Rades D, Hoskin PJ, Stalpers LJ, Schulte R, Poortmans P, Veninga T, Dahm-Daphi J, Obralic N, Wildfang I, Bahrehmand R, Engenhart-Cabilic R, Schild SE. Rades D, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1452-7. doi: 10.1016/j.ijrobp.2005.10.018. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16413695
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study.
Monnard V, Sun A, Epelbaum R, Poortmans P, Miller RC, Verschueren T, Scandolaro L, Villa S, Majno SB, Ostermann S, Ozsahin M, Mirimanoff RO. Monnard V, et al. Among authors: poortmans p. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):817-23. doi: 10.1016/j.ijrobp.2006.01.002. Epub 2006 Mar 15. Int J Radiat Oncol Biol Phys. 2006. PMID: 16542791 Free article.
419 results